Cargando…
Posterior Reversible Encephalopathy Syndrome Triggered by Obinutuzumab in a Patient with Chronic Lymphocytic Leukemia
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder that can affect all age groups. It appears to have a higher incidence in the female population. Some common risk factors include hypertension, electrolyte abnormalities, sepsis, and chemotherapeutic medications such as Ob...
Autores principales: | Atef, Bentolhoda, Abdelazeem, Basel, Qureshi, Khadija, Ghatol, Abhijeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Greater Baltimore Medical Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589023/ https://www.ncbi.nlm.nih.gov/pubmed/37868249 http://dx.doi.org/10.55729/2000-9666.1216 |
Ejemplares similares
-
Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021) -
Pulmonary Fibrosis After COVID-19 Pneumonia
por: Malik, Bilal, et al.
Publicado: (2021) -
Rapidly reversible visual loss in posterior reversible encephalopathy syndrome: An ophthalmologist's enigma
por: Sachdeva, Virender, et al.
Publicado: (2015) -
Hypercalcemia-Associated Posterior Reversible Encephalopathy
Syndrome
por: Mirian, Ario, et al.
Publicado: (2021) -
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter, Karen, et al.
Publicado: (2015)